A detailed history of Mill Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Mill Capital Management, LLC holds 51,533 shares of BMY stock, worth $2.12 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
51,533
Previous 55,801 7.65%
Holding current value
$2.12 Million
Previous $2.86 Million 2.41%
% of portfolio
0.24%
Previous 0.26%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$47.98 - $54.4 $204,778 - $232,179
-4,268 Reduced 7.65%
51,533 $2.79 Million
Q2 2023

Jul 20, 2023

BUY
$63.71 - $70.74 $103,210 - $114,598
1,620 Added 2.99%
55,801 $3.57 Million
Q1 2023

May 01, 2023

SELL
$65.71 - $74.53 $178,402 - $202,348
-2,715 Reduced 4.77%
54,181 $3.76 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $3.05 Million - $3.56 Million
56,896 New
56,896 $3.55 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $87.4B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Mill Capital Management, LLC Portfolio

Follow Mill Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mill Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mill Capital Management, LLC with notifications on news.